enVVeno Medical Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
enVVeno Medical Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2017 to Q4 2024.
  • enVVeno Medical Corp Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$6.23M, a 10.3% decline year-over-year.
  • enVVeno Medical Corp Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$21.8M, a 7.22% increase year-over-year.
  • enVVeno Medical Corp annual Net Income (Loss) Attributable to Parent for 2024 was -$21.8M, a 7.22% increase from 2023.
  • enVVeno Medical Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$23.5M, a 4.67% increase from 2022.
  • enVVeno Medical Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$24.7M, a 49.3% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$21.8M -$6.23M -$580K -10.3% Oct 1, 2024 Dec 31, 2024 10-K/A 2025-02-28
Q3 2024 -$21.2M -$5.64M -$641K -12.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 -$20.6M -$4.96M +$1.52M +23.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 -$22.1M -$4.99M +$1.4M +21.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$23.5M -$5.65M +$531K +8.59% Oct 1, 2023 Dec 31, 2023 10-K/A 2025-02-28
Q3 2023 -$24M -$5M +$1.1M +18% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 -$25.1M -$6.47M +$588K +8.33% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 -$25.7M -$6.39M -$1.06M -19.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$24.7M -$6.18M +$2.81M +31.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$27.5M -$6.1M -$3.71M -155% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 -$23.8M -$7.06M -$4.68M -197% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-31
Q1 2022 -$19.1M -$5.33M -$2.56M -92.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 -$16.5M -$8.99M -$4.61M -105% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$11.9M -$2.39M -$414K -21% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 -$11.5M -$2.38M -$751K -46.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-10-27
Q1 2021 -$10.7M -$2.77M -$1.61M -139% Jan 1, 2021 Mar 31, 2021 10-Q 2022-10-27
Q4 2020 -$9.14M -$4.37M -$2.08M -90.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$7.05M -$1.97M -$160K -8.81% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$6.89M -$1.63M +$319K +16.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$7.21M -$1.16M +$414K +26.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$7.63M -$2.29M -$509K -28.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$7.12M -$1.81M -$347K -23.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-17
Q2 2019 -$6.77M -$1.95M +$3.1M +61.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-17
Q1 2019 -$9.87M -$1.57M +$3.17M +66.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-17
Q4 2018 -$13M -$1.78M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-18
Q3 2018 -$1.47M +$787K +34.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 -$5.05M -$3.8M -304% Apr 1, 2018 Jun 30, 2018 10-Q 2019-10-31
Q1 2018 -$4.75M Jan 1, 2018 Mar 31, 2018 10-Q 2019-10-31
Q3 2017 -$2.25M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$1.25M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.